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Abstract
Myxomas are the most frequent benign primary cardiac tumours (50% of benign heart tumours). This kind of
tumour is most likely to be localized in the left atrium, followed by the right atrium, right ventricle and left ventri-
cle. Quite exceptional is the presence of a myxoma originating from the tricuspid valve or from the Eustachian
valve. We describe the case of a woman with moderate dyspnoea of unknown origin and the presence of tricus-
pid myxoma who underwent tricuspid valve curettage.
Background
Myxomas are the most frequent benign primary cardiac
tumours (50% of benign heart tumours). They are most
commonly detected in people between 30 and 60 years
of age, although published findings report congenital
myxomas, tumours developed during childhood and
even in extremely old patients. This kind of tumour is
most likely to be localized in the left atrium (75%), fol-
lowed by the right atrium (18%), right ventricle (4%)
and left ventricle (3%) [1,2]. Quite exceptional is the
presence of a myxoma originating from the tricuspid
valve [3,4] or from the Eustachian valve [5].
Case Report
A 44-year-old woman was evaluated for moderate dys-
pnoea of unknown origin. She had already undergone
other clinical and instrumental tests that had ruled out
pulmonary genesis. Transthoracic echocardiography
revealed a mobile hyperlucent mass measuring 0.9 × 1.6
cm, with suspected tumoral myxoma located on the sep-
tal leaflet of the tricuspid valve and moving through and
from the tricuspidal annulus (Figs. 1 and 2), with mod-
erate tricuspid regurgitation and mild valve stenosis
(mean gradient 8 mmHg, systolic pulmonary artery 45
mmHg). The patient underwent chest X-ray examina-
tion and thoracic CT, revealing no pathological
condition.
Surgical removal with tricuspid valve curettage was
performed to improve the symptoms of congestive heart
failure and prevent pulmonary embolism. Histological
examination of the mass confirmed the diagnosis of
myxoma and its benign nature. The postoperative
course was uneventful and follow-up examination
showed complete normalization of the Doppler echocar-
diographic parameters and the absence of clinical symp-
toms (i.e. dyspnoea).
Discussion
Myxomas are rarely localized in the right heart originat-
i n gf r o mt h er i g h ta t r i u mo rf r o mt h et r i c u s p i dv a l v e ;
they usually present symptoms related to low cardiac
output or to pulmonary arterial hypertension with hepa-
tomegaly, oedema, ascites and cyanosis. This clinical
picture varies, however, with the position of the tumour.
The literature reports patients who were symptomatic
for syncopes and dyspnoea [1,2] or embolic manifesta-
tions that usually involved the lungs [6,7]. In the case of
friable polypoid myxomas there may also be multiple
pulmonary embolism [8], frequently mistaken for a sep-
tic embolus, which can lead to severe pulmonary hyper-
tension and sometimes also to aneurisms of the
pulmonary arteries [9]. Lastly, in the case of a right-to-
left shunt at an atrial level, paradoxical embolism of the
brain and kidneys and aortic bifurcation may occur [10].
Resection of the tumour constitutes the definitive treat-
ment for cardiac myxomas, using different techniques
based on the location of the tumour in order to control
embolization. In the case of tricuspid valve myxomas,
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any medium, provided the original work is properly cited.tumour excision, tricuspid valvuloplasty or valve replace-
ment may also be necessary. Surgery mortality is around
1% and relapses are possible (1-5% of all cases). Recur-
rences are usually due to metastatic dissemination or
incomplete resection of the lesion and arise within 48
months of the operation [11-13]. Our clinical case high-
lights once more the absence and the non-specificity of
the clinical manifestation of cardiac myxomas, especially
when located in the right heart. Furthermore, as well
established in the literature, this case stresses the impor-
tance and reliability of two-dimensional echocardiograpy
for diagnosis of the tumour mass thanks to direct visua-
lization of the tricuspid leaflets and normalization of the
haemodynamic parameters.
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Figure 1 Echocardiographic image of tricuspid mass.
Figure 2 Image of mass through the tricuspid valve.
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